Genetically Modified Food Safety Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Crops is the fastest growing sector, North America is the largest market

The Global Genetically Modified Food Safety Testing Market is projected to expand from USD 3.02 billion in 2025 to USD 4.75 billion by 2031, at a compound annual growth rate (CAGR) of 7.84%. This market encompasses the analytical and verification processes crucial for ensuring genetically engineered agricultural products meet rigorous health and environmental standards before entering the supply chain.

Its growth is primarily fueled by the increasing global cultivation of biotech crops and the intensifying demand for food security, which necessitates strict adherence to international trade regulations to prevent supply chain disruptions. For instance, in 2025, the International Service for the Acquisition of Agri-biotech Applications reported 534 global approvals for genetically modified crops across cultivation, food, and feed uses, underscoring the vital need for validated safety assessments. A significant challenge, however, is the lack of regulatory harmonization across different jurisdictions, leading to varied approval timelines and tolerance levels for low-level GMO presence, which complicates trade, escalates compliance costs, and can delay the commercial introduction of new biotech varieties.

Market Drivers

A primary catalyst for the market is the implementation of stringent global regulatory frameworks and mandatory labeling requirements, which compel exporters to adopt rigorous screening protocols to navigate complex international compliance landscapes. Nations enforcing zero-tolerance policies or strict labeling thresholds for unapproved biotech events intensify the demand for comprehensive verification processes, aiming to prevent border rejections and trade disputes. This growing operational burden is reflected in rising safety alerts, with the Rapid Alert System for Food and Feed recording an 8% increase to 4,695 notifications in March 2025, as per Merieux NutriSciences.

To bolster enforcement, governments are actively funding analytical capabilities; for example, the Food Standards Agency allocated £1.2 million across 17 National Reference Laboratory areas in January 2025 to maintain and enhance national testing proficiency. Further accelerating the necessity for robust safety testing is the substantial expansion in the commercial cultivation of genetically modified crops, which increases the volume of biotech commodities in the global supply chain. The widespread adoption of engineered varieties in key agricultural regions elevates the risk of commingling, requiring frequent checks to verify non-GMO status or confirm trait purity for identity-preserved markets. This market dominance is evident from USDA statistics in June 2025, showing 94% of all U.S. corn acres were biotech varieties, highlighting the ubiquity of these crops and the consequent need for high-throughput diagnostic solutions to manage genetically modified ingredients and ensure compliance with safety standards.

Market Challenges

The Global Genetically Modified Food Safety Testing Market faces a considerable impediment due to the fragmented regulatory landscape across various international jurisdictions. This absence of harmonized regulations forces testing laboratories and exporters to contend with asynchronous approval timelines and differing tolerance thresholds for genetically modified organisms. When a biotech trait receives approval in one country but not another, it mandates the development and application of multiple, distinct analytical protocols to satisfy each market's specific zero-tolerance or low-level presence policies.

This regulatory complexity directly hinders market expansion by increasing the operational costs and technical burdens associated with safety verification, potentially discouraging smaller entities from participating in international trade. Consequently, these extensive compliance demands prolong the commercialization process for new agricultural biotechnology products, thereby decreasing the volume of novel varieties entering the supply chain that would require testing. The impact of these regulatory bottlenecks is substantial, as reported by CropLife International in 2024, where rigorous and disparate global regulatory environments contributed to an average development period of approximately 16 years and a cost of nearly USD 115 million to introduce a new biotech plant trait to market. Such protracted timelines deter investment in new product development, ultimately stagnating the demand for associated safety testing services and limiting the market's potential growth.

Market Trends

The market is currently undergoing a notable shift towards outsourced third-party testing services, primarily spurred by the high capital expenditures required to maintain advanced diagnostic capabilities, such as Next-Generation Sequencing and digital PCR. As the financial burden of establishing state-of-the-art in-house facilities escalates, smaller and mid-sized food manufacturers are increasingly engaging accredited reference laboratories to ensure adherence to complex global regulations.

This industry consolidation is exemplified by the operational expansion of key service providers; for instance, Mérieux NutriSciences expanded its global network to over 140 accredited laboratories following its acquisition of Bureau Veritas' Food Testing Business in September 2025. Simultaneously, there is a widespread proliferation of rapid point-of-need testing devices, which enable immediate decision-making earlier in the supply chain. Stakeholders are moving away from an exclusive reliance on central laboratories for initial screening, instead favoring portable solutions like lateral flow devices and mobile PCR units that allow farmers and grain elevators to verify crop purity on-site. This growing demand for decentralized testing solutions is reflected in the financial performance of market leaders, with Neogen Corporation reporting preliminary quarterly revenues of USD 231.3 million in January 2025, attributing this success to accelerating core revenue growth within its Food Safety segment.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Bureau Veritas SA
• Emsl Analytical Inc.
• Eurofins Scientific SE
• Thermo Fisher Scientific Inc.
• SGS SA
• Intertek Group Plc
• Genetic ID NA Inc.
• ALS Limited
• Assure Quality Limited

Report Scope

In this report, the Global Genetically Modified Food Safety Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genetically Modified Food Safety Testing Market, by Food Type:

• Crops
• Processed Foods
• Others

Genetically Modified Food Safety Testing Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genetically Modified Food Safety Testing Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.